214 related articles for article (PubMed ID: 25621144)
1. Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery.
Zheng YR; Suntharalingam K; Johnstone TC; Lippard SJ
Chem Sci; 2015 Feb; 6(2):1189-1193. PubMed ID: 25621144
[TBL] [Abstract][Full Text] [Related]
2. Poly(β-cyclodextrin)/platinum prodrug supramolecular nano system for enhanced cancer therapy: Synthesis and in vivo study.
Zhang R; You X; Luo M; Zhang X; Fang Y; Huang H; Kang Y; Wu J
Carbohydr Polym; 2022 Sep; 292():119695. PubMed ID: 35725183
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular platinum complexes for cancer therapy.
Jogadi W; Zheng YR
Curr Opin Chem Biol; 2023 Apr; 73():102276. PubMed ID: 36878171
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
Braga CB; Perli G; Becher TB; Ornelas C
Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
[TBL] [Abstract][Full Text] [Related]
5. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
6. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
7. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
[TBL] [Abstract][Full Text] [Related]
8. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
[TBL] [Abstract][Full Text] [Related]
9. An Anticancer Pt
Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt
Reshetnikov V; Daum S; Mokhir A
Chemistry; 2017 Apr; 23(24):5678-5681. PubMed ID: 28319647
[TBL] [Abstract][Full Text] [Related]
12. A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes.
Ong JX; Lim CSQ; Le HV; Ang WH
Angew Chem Int Ed Engl; 2019 Jan; 58(1):164-167. PubMed ID: 30407697
[TBL] [Abstract][Full Text] [Related]
13. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
[TBL] [Abstract][Full Text] [Related]
14. Interactions between mitochondria-damaging platinum(IV) prodrugs and cytochrome c.
Jayawardhana AMDS; Zheng YR
Dalton Trans; 2022 Feb; 51(5):2012-2018. PubMed ID: 35029256
[TBL] [Abstract][Full Text] [Related]
15. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling porphyrin conjugate-carboplatin(IV) prodrug nanoparticles for enhancing high efficacy nasopharyngeal cancer and low systemic toxicity.
Su R; Zhang X; Peng Q; Wang W
J Biomater Sci Polym Ed; 2022 Oct; 33(14):1828-1844. PubMed ID: 35686461
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Cisplatin(IV) Prodrug-Tethered CuFeS
Girma WM; Tzing SH; Tseng PJ; Huang CC; Ling YC; Chang JY
ACS Appl Mater Interfaces; 2018 Feb; 10(5):4590-4602. PubMed ID: 29336140
[TBL] [Abstract][Full Text] [Related]
18. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device.
Dhar S; Liu Z; Thomale J; Dai H; Lippard SJ
J Am Chem Soc; 2008 Aug; 130(34):11467-76. PubMed ID: 18661990
[TBL] [Abstract][Full Text] [Related]
19. Image-Guided Nanodelivery of Pt(IV) Prodrugs to GRP-Receptor Positive Tumors.
Silva F; Mendes C; D'Onofrio A; Campello MPC; Marques F; Pinheiro T; Gonçalves K; Figueiredo S; Gano L; Ravera M; Gabano E; Paulo A
Nanotheranostics; 2023; 7(1):22-40. PubMed ID: 36593794
[TBL] [Abstract][Full Text] [Related]
20. Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy.
Zheng S; Li G; Shi J; Liu X; Li M; He Z; Tian C; Kamei KI
J Control Release; 2023 Sep; 361():819-846. PubMed ID: 37597809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
